1Amin AF, Abd EA, Darwish AM, et al. Evaluation of the in pact of laparoscopie ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome[J]. Fertil Steril, 2003, 79 (4) : 938 - 941.
2Vrbikova J, Cibula D. Combined oral contraceptives in the treatment of polycystic ovary syndrome[J]. Hum Reprod Update, 2005,11(3) :277 - 291.
3Dragisic K, Bongiovanni A, Liu H, et al. Insulin growth factor- 1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in PCOS IVF patients: correlationswith outcome [J]. Fertil Steril, 2005,84 ( Suppl 1 ) : S4.
7Seifer DB, Scott RT, Bergh PA, et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone[J]. Fertil Steril, 1999,72(1) :63 - 65.
8Laven JSE, Imani B, Eijkemans MJC, et al. Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility [ J ]. Hum Reprod, 2001, 16: 1359- 1364.
9Norman RJ, Clyde Milner CR, Milner, Nigel P. Groome. Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome [J]. Human Reproduction, 2001,16(4) : 668 - 672.
9Roberts VJ, Barth S, El - Roeiy A, et al. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome. J Clin Endocrinol Metab, 1994, 79: 1434- 1439.
10Lu C, Yang W, Chen M, et al. Inhibin A inhibits follicle- stimulating hormone (FSH) action by suppressing its receptor expression in cultured rat granulosa cells. Mol Cell Endocrinol, 2009, 298: 48-56.
